• 1
    Davey DD,Neal MH,Wilbur DC,Colgan TJ,Styer PE,Mody DR. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2004; 128: 12241229.
  • 2
    Eltoum IA,Roberson J. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS). Cancer. 2007; 111: 3440.
  • 3
    Alli PM,Ali SZ. Atypical squamous cells of undetermined significance—rule out high-grade squamous intraepithelial lesion: cytopathologic characteristics and clinical correlates. Diagn Cytopathol. 2003; 28: 308312.
  • 4
    Duncan LD,Jacob SV. Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion: the practice experience of a hospital-based reference laboratory with this new Bethesda System diagnostic category. Diagn Cytopathol. 2005; 32: 243246.
  • 5
    Genest DR,Dean B,Lee KR,Sheets E,Crum CP,Cibas ES. Qualifying the cytologic diagnosis of “atypical squamous cells of undetermined significance” affects the predictive value of a squamous intraepithelial lesion on subsequent biopsy. Arch Pathol Lab Med. 1998; 122: 338341.
  • 6
    Liman AK,Giampoli EJ,Bonfiglio TA. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion receive reflex human papillomavirus-DNA testing? Cancer (Cancer Cytopathol). 2005; 105: 457460.
  • 7
    McHale MT,Souther J,Elkas JC,Monk BJ,Harrison TA. Is atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion clinically significant? J Low Genit Tract Dis. 2007; 11: 8689.
  • 8
    Malik SN,Wilkinson EJ,Drew PA, et al. Do qualifiers of ASCUS distinguish between low- and high-risk patients? Acta Cytol. 1999; 43: 376380.
  • 9
    Schoolland M,Sterrett GF,Knowles SA,Mitchell KM,Kurinczuk JJ. The “inconclusive—possible high grade epithelial abnormality” category in Papanicolaou smear reporting. Cancer (Cancer Cytopathol). 1998; 84: 208217.
  • 10
    Selvaggi SM. Reporting of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: is it significant? Diagn Cytopathol. 2003; 29: 3841.
  • 11
    Sherman ME,Solomon D,Schiffman M; ASCUS LSIL Triage Study Group. Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol. 2001; 116: 386394.
  • 12
    Sherman ME,Tabbara SO,Scott DR, et al. “ASCUS rule out HSIL”: cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol. 1999; 12: 335342.
  • 13
    Quddus MR,Sung CJ,Steinhoff MM,Lauchlan SC,Singer DB,Hutchinson ML. Atypical squamous metaplastic cells: reproducibility, outcome, and diagnostic features on ThinPrep Pap test. Cancer (Cancer Cytopathol). 2001; 93: 1622.
  • 14
    Louro AP,Roberson J,Eltoum I,Chhieng DC. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion. A follow-up study of conventional and liquid-based preparations in a high-risk population. Am J Clin Pathol. 2003; 120: 392397.
  • 15
    Onuma K,Saad RS,Kanbour-Shakir A,Kanbour AI,Dabbs DJ. Clinical implications of the diagnosis “atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion” in pregnant women. Cancer. 2006; 108: 282287.
  • 16
    Wu HH,Allen SL,Kirkpatrick JL,Elsheikh TM. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion. Diagn Cytopathol. 2006; 34: 707710.
  • 17
    Srodon M,Parry Dilworth H,Ronnett BM. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results. Cancer. 2006; 108: 3238.
  • 18
    Sherman ME,Castle PE,Solomon D. Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes. Cancer. 2006; 108: 298305.
  • 19
    Saad RS,Dabbs DJ,Kordunsky L, et al. Clinical significance of cytologic diagnosis of atypical squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women. Am J Clin Pathol. 2006; 126: 381388.
  • 20
    Reid-Nicholson M,Gatscha RM,Riedel ER,Lin O. Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter? Diagn Cytopathol. 2007; 35: 15.
  • 21
    Barreth D,Schepansky A,Capstick V,Johnson G,Steed H,Faught W. Atypical squamous cells—cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a result not to be ignored. J Obstet Gynaecol Can. 2006; 28: 10951098.
  • 22
    Chivukula M,Shidham VB. ASC-H in Pap test—definitive categorization of cytomorphological spectrum. Cytojournal. 2006; 3: 14.
  • 23
    Bhanot UK. Atypical squamous cells: ASCUS is out! Now, ASC-US and ASC-H for reporting of cervical cytology. Asian Pac J Cancer Prev. 2006; 7: 161162.
  • 24
    Lee SJ,Jung KL,Lee JW, et al. Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management. Int J Gynecol Cancer. 2006; 16: 664669.
  • 25
    Simsir A,Ioffe O,Sun P,Elgert P,Cangiarella J,Levine PH. Effect of Bethesda 2001 on reporting of atypical squamous cells (ASC) with special emphasis on atypical squamous cells-cannot rule out high grade (ASC-H). Diagn Cytopathol. 2006; 34: 6266.
  • 26
    Kir G,Cetiner H,Gurbuz A,Karateke A. Reporting of “LSIL with ASC-H” on cervicovaginal smears: is it a valid category to predict cases with HSIL follow-up? Eur J Gynaecol Oncol. 2004; 25: 462464.
  • 27
    Quddus MR,Sung CJ,Eklund MJ,Zhang C,Steinhoff MM. Atypical squamous cells, cannot exclude HSIL: a review of original vs. duplicate thin-layer slides. J Reprod Med. 2004; 49: 457462.
  • 28
    Rowe LR,Aldeen W,Bentz JS. Prevalence and typing of HPV DNA by hybrid capture II in women with ASCUS, ASC-H, LSIL, and AGC on ThinPrep Pap tests. Diagn Cytopathol. 2004; 30: 426432.
  • 29
    SolomonD, NayarR. Eds. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes.2nd Ed. New York: Springer; 2004.
  • 30
    Wright TCJr,Cox JT,Massad LS,Twiggs LB,Wilkinson EJ; ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002; 287: 21202129.